Charles Elliott Sigal Insider Trading $SURF Surface Oncology, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Charles Elliott Sigal.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Charles Elliott Sigal. Charles Elliott Sigal is Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in Surface Oncology, Inc. ($SURF) and Director in Vir Biotechnology, Inc. ($VIR).

Charles Elliott Sigal in Surface Oncology, Inc.

Trading Symbol: SURF
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Charles Elliott Sigal: Director
Holdings: 45,453 shares
Latest Transaction: Jun 12 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Charles Elliott Sigal in Surface Oncology, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADAP, SURF, VIR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 12 2020SURFSurface Oncology, ...Sigal Charles ElliottDirectorOption ExerciseA4.3512,00052,20012,000
Oct 03 2019SURFSurface Oncology, ...Sigal Charles ElliottDirectorOption ExerciseA1.1713,57215,87913,572
Jun 06 2019SURFSurface Oncology, ...Sigal Charles ElliottDirectorOption ExerciseA3.6912,10044,64912,100
Jun 06 2019SURFSurface Oncology, ...Sigal Charles ElliottDirectorOption ExerciseA3.6912,10044,64912,100
Jul 05 2018SURFSurface Oncology, ...Sigal Charles ElliottDirectorOption ExerciseA16.838,882149,4848,882
Apr 23 2018SURFSurface Oncology, ...Sigal Charles ElliottDirectorOption ExerciseC0.00100,00000
Apr 23 2018SURFSurface Oncology, ...Sigal Charles ElliottDirectorBuyC0.0045,453045,4530 to 45.5 K

Page:   1